Abstract
Intravenous (IV) drug administation is a common procedure requiring venous cannulation. Despite its prevalence, IV therapy has several associated risks, such as infection, phelbitis, hypervolaemia and anaphylaxis. This article provides a brief overview of current clinical guidance on IV therapy and the current challenges in terms of infection control and ensuring patient safety.
Original language | English |
---|---|
Pages (from-to) | 264-268 |
Number of pages | 5 |
Journal | British Journal of Healthcare Management |
Volume | 21 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2015 |
Keywords
- Clinical guidance
- Infection prevention
- Intravenous therapy
- Patient safety